Monday, 22 Aug 2011 05:38pm EDT
Skystar Bio-Pharmaceutical Company (SKBI.NSDQ)announced that for fiscal 2011, it expects revenue guidance to be in the range of $52 million to $55 million.
Source:Reuters
Welcome to our website. This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com